TW
Timothy Williams
SVP & General Counsel

Timothy Williams insider trades: Vanda Pharmaceuticals (VNDA) stock sales

SVP & General Counsel, Vanda Pharmaceuticals Last trade Mar 2, 2026 23 Form 4 filings
$351K
Sold, last 12 months
1 sale
$0
Bought, last 12 months
0 buys
13
Open-market trades
since 2019
2
Companies
last trade 2026

Trades on the price chart

Daily close, with an arrow on each day they bought or sold

Companies

Where Timothy reports to the SEC

Open-market buys and sales

13 trades reported on SEC Form 4, newest first

DateStockTypeValue
Mar 2, 2026VNDA↓ Sell$351K
Mar 5, 2024VNDA↓ Sell$73K
Jun 13, 2023VNDA↓ Sell$96K
Mar 3, 2023VNDA↓ Sell$105K
Dec 15, 2022VNDA↓ Sell$56K
Aug 15, 2022VNDA↓ Sell$86K
Mar 2, 2022VNDA↓ Sell$134K
Aug 16, 2021VNDA↓ Sell$60K
Mar 5, 2021VNDA↓ Sell$100K
Mar 2, 2021VNDA↓ Sell$363K
Aug 14, 2020VNDA↓ Sell$44K
Mar 3, 2020VNDA↓ Sell$45K
Aug 14, 2019VNDA↓ Sell$38K

Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.

Other VNDA insiders

Open-market trades in the last 12 months

About Timothy Williams's insider trades

Timothy Williams is SVP & General Counsel at Vanda Pharmaceuticals (VNDA). Since Aug 14, 2019, Timothy has reported no open-market purchases and 13 sales worth $1.5M on SEC Form 4. In the last 12 months: 1 sale ($351K).

Their filings also include grants and awards (10 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.

How to read insider trades

Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every VNDA insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.